Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)Ended earlyNCT00017277What this trial is testingRadiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC 47
Testing effectiveness (Phase 2)Study completedNCT04139057What this trial is testingEBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCCWho this might be right forHead and Neck Squamous Cell Carcinoma Xinqiao Hospital of Chongqing 10
Large-scale testing (Phase 3)Study completedNCT00193895What this trial is testingPost-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and NeckWho this might be right forSkin Cancer Trans Tasman Radiation Oncology Group 321
Large-scale testing (Phase 3)Study completedNCT00002839What this trial is testingCombination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or LarynxWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC 564
Early research (Phase 1)Study completedNCT00005647What this trial is testingSU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckWho this might be right forHead and Neck Cancer Case Comprehensive Cancer Center 12
Early research (Phase 1)Not Yet RecruitingNCT07814248What this trial is testingA Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid TumorsWho this might be right forNSCLC (Non-small Cell Lung Cancer)HNSCCEndometrial+5 more TwoStep Therapeutics, Inc. 74
Not applicableLooking for participantsNCT06744296What this trial is testingMeasurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and NeckWho this might be right forSquamous Cell Carcinoma of Head and Neck Massachusetts Eye and Ear Infirmary 75
Large-scale testing (Phase 3)Looking for participantsNCT05333523What this trial is testingPersonalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.Who this might be right forLaryngeal Squamous Cell CarcinomaHypopharynx Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma Radboud University Medical Center 242
Testing effectiveness (Phase 2)Study completedNCT05383170What this trial is testingEvaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic CancersWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Breast CancerAdvanced Melanoma Cytovation AS 6
Testing effectiveness (Phase 2)Looking for participantsNCT06107686What this trial is testingYL202 in Selected Patients With Advanced Solid TumorsWho this might be right forNSCLCBreast CancerHNSCC+1 more MediLink Therapeutics (Suzhou) Co., Ltd. 200
Early research (Phase 1)UnknownNCT05299203What this trial is testingBH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)Who this might be right forHead and Neck Squamous Cell Carcinoma West China Hospital 18
Not applicableStudy completedNCT04050761What this trial is testingNivolumab in Patients With Head and Neck Cancer.Who this might be right forSquamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck Bristol-Myers Squibb 502
Not applicableLooking for participantsNCT05872880What this trial is testingTPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.Who this might be right forOral Squamous Cell CarcinomaLocally Advanced Head and Neck Squamous Cell Carcinoma Xiangya Hospital of Central South University 124
Not applicableStudy completedNCT00851253What this trial is testingStereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Boston Medical Center 12
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT03565445What this trial is testingASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Astellas Pharma Global Development, Inc. 190
Testing effectiveness (Phase 2)Study completedNCT02707588What this trial is testingTolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCCWho this might be right forSquamous Cell Carcinoma of the Head and Neck Groupe Oncologie Radiotherapie Tete et Cou 133
Early research (Phase 1)Looking for participantsNCT07348211What this trial is testingFirst in Human Study of SIM0610 in Solid TumorsWho this might be right forAdvanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Testing effectiveness (Phase 2)UnknownNCT04297995What this trial is testingEvaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck TumorsWho this might be right forHead and Neck Squamous Cell Carcinoma Shanghai Henlius Biotech 131